It was reported that this compound could sensitize several types of cancer cell lines to a number of chemotherapeutic agents.30, 31, 32 We demonstrated that MK-1775 potentiated Wip1-dependent sensitization to cisplatin in p53-negative Saos2 cells, even with a lower cisplatin concentration (P=0.0099). This evidence concerns the gene PPM1D and cancer.